Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. 2002

Atsuko Kamijo, and Kenjiro Kimura, and Takeshi Sugaya, and Masaya Yamanouchi, and Hiromi Hase, and Tomoyo Kaneko, and Yasunobu Hirata, and Atsuo Goto, and Toshiro Fujita, and Masao Omata
Internal Medicine, the University of Tokyo, Tokyo, Japan.

BACKGROUND Evidence indicates that urinary protein is associated with tubulointerstitial damage and thus it is an aggravating factor for chronic renal disease. As free fatty acids (FFAs) are bound to serum albumin, we hypothesized that FFAs were overloaded to the proximal tubule in massive proteinuria and thus caused tubulointerstitial damage. To test this hypothesis, massive proteinuria was provoked in mice and the renal damage examined. METHODS Mice were intraperitoneally injected with bovine serum albumin (BSA) replete with FFAs (r-BSA group, N = 10), FFA-depleted BSA (d-BSA group, N = 10), or saline (saline group, N = 9) for 14 days. RESULTS The kidneys of the r-BSA group showed severe tubulointerstitial damage and those of the d-BSA group showed mild tubulointerstitial damage. Urinary excretion of both total protein and mouse albumin were significantly higher in the r-BSA group than in the d-BSA group. To examine the proximal tubular uptake of albumin, the BSA content in the cultured mouse proximal tubules was measured by ELISA after 90 minutes of incubation with each BSA. In terms of the BSA content in the proximal tubules, there was no significant difference between the r-BSA and the d-BSA groups. These results indicate that r-BSA and d-BSA were similarly reabsorbed into the proximal tubule and that r-BSA causes severe tubulointerstitial damage. CONCLUSIONS It is the FFAs bound to albumin, rather than albumin itself, which cause severe tubulointerstitial damage by being reabsorbed into the proximal tubule. To our knowledge, this is the first in vivo observation in which FFAs have caused severe tubulointerstitial injury.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007687 Kidney Tubules, Proximal The renal tubule portion that extends from the BOWMAN CAPSULE in the KIDNEY CORTEX into the KIDNEY MEDULLA. The proximal tubule consists of a convoluted proximal segment in the cortex, and a distal straight segment descending into the medulla where it forms the U-shaped LOOP OF HENLE. Proximal Kidney Tubule,Proximal Renal Tubule,Kidney Tubule, Proximal,Proximal Kidney Tubules,Proximal Renal Tubules,Renal Tubule, Proximal,Renal Tubules, Proximal,Tubule, Proximal Kidney,Tubule, Proximal Renal,Tubules, Proximal Kidney,Tubules, Proximal Renal
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005260 Female Females

Related Publications

Atsuko Kamijo, and Kenjiro Kimura, and Takeshi Sugaya, and Masaya Yamanouchi, and Hiromi Hase, and Tomoyo Kaneko, and Yasunobu Hirata, and Atsuo Goto, and Toshiro Fujita, and Masao Omata
May 2015, BioTechniques,
Atsuko Kamijo, and Kenjiro Kimura, and Takeshi Sugaya, and Masaya Yamanouchi, and Hiromi Hase, and Tomoyo Kaneko, and Yasunobu Hirata, and Atsuo Goto, and Toshiro Fujita, and Masao Omata
May 1978, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
Atsuko Kamijo, and Kenjiro Kimura, and Takeshi Sugaya, and Masaya Yamanouchi, and Hiromi Hase, and Tomoyo Kaneko, and Yasunobu Hirata, and Atsuo Goto, and Toshiro Fujita, and Masao Omata
February 1966, Archives of pathology,
Atsuko Kamijo, and Kenjiro Kimura, and Takeshi Sugaya, and Masaya Yamanouchi, and Hiromi Hase, and Tomoyo Kaneko, and Yasunobu Hirata, and Atsuo Goto, and Toshiro Fujita, and Masao Omata
August 1970, Clinica chimica acta; international journal of clinical chemistry,
Atsuko Kamijo, and Kenjiro Kimura, and Takeshi Sugaya, and Masaya Yamanouchi, and Hiromi Hase, and Tomoyo Kaneko, and Yasunobu Hirata, and Atsuo Goto, and Toshiro Fujita, and Masao Omata
June 1979, Biochemical and biophysical research communications,
Atsuko Kamijo, and Kenjiro Kimura, and Takeshi Sugaya, and Masaya Yamanouchi, and Hiromi Hase, and Tomoyo Kaneko, and Yasunobu Hirata, and Atsuo Goto, and Toshiro Fujita, and Masao Omata
May 1972, Acta paediatrica Scandinavica,
Atsuko Kamijo, and Kenjiro Kimura, and Takeshi Sugaya, and Masaya Yamanouchi, and Hiromi Hase, and Tomoyo Kaneko, and Yasunobu Hirata, and Atsuo Goto, and Toshiro Fujita, and Masao Omata
April 1988, Biochimica et biophysica acta,
Atsuko Kamijo, and Kenjiro Kimura, and Takeshi Sugaya, and Masaya Yamanouchi, and Hiromi Hase, and Tomoyo Kaneko, and Yasunobu Hirata, and Atsuo Goto, and Toshiro Fujita, and Masao Omata
March 1975, Journal of lipid research,
Atsuko Kamijo, and Kenjiro Kimura, and Takeshi Sugaya, and Masaya Yamanouchi, and Hiromi Hase, and Tomoyo Kaneko, and Yasunobu Hirata, and Atsuo Goto, and Toshiro Fujita, and Masao Omata
December 2013, Biochimica et biophysica acta,
Atsuko Kamijo, and Kenjiro Kimura, and Takeshi Sugaya, and Masaya Yamanouchi, and Hiromi Hase, and Tomoyo Kaneko, and Yasunobu Hirata, and Atsuo Goto, and Toshiro Fujita, and Masao Omata
December 1989, Indian journal of biochemistry & biophysics,
Copied contents to your clipboard!